Request Legal Help Now - Free
LAWSUITS NEWS & LEGAL INFORMATION
Home Page >> FDA Pulls Zofran 32 mg due to Potential For Serious Cardiac Risks >> Articles

Zofran Cardiac Risk Articles

Families Ask GSK to Hand Over Zofran Data

Families Ask GSK to Hand Over Zofran Data February 27, 2018. By Lucy Campbell.
Washington, DC: Families of patients who allegedly suffered birth defects while taking GlaxoSmithKline’s (GSK) anti-nausea drug Zofran, and who are suing the drug maker in multi-district litigating (MDL) are asking that the drug maker hand over data stored in a drug safety database called “Argus.”
Read [ Families Ask GSK to Hand Over Zofran Data ]

Zofran Litigation Making Progress

Zofran Litigation Making Progress September 12, 2016. By Jane Mundy.
Houston, TX: Another Zofran lawsuit filed by parents in Texas joins more than 300 suits filed nationwide against the manufacturer. Most all federal cases consolidated into a multidistrict litigation in Massachusetts are making progress and a first trial date is expected soon.
Read [ Zofran Litigation Making Progress ]

Zofran Complaints Mounting with Increased Awareness of Birth Defects

Zofran Complaints Mounting with Increased Awareness of Birth Defects August 10, 2016. By Jane Mundy.
Birmingham, AL: Many women who took Zofran during their pregnancy had idea that it is prescribed “off-label”, meaning it wasn’t approved by the FDA to treat morning sickness.
Read [ Zofran Complaints Mounting with Increased Awareness of Birth Defects ]

Request Legal Help Now! - Free